AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 9:36 AM ISTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study Garima18 May 2019 9:30 AM ISTAbrocitinib, which belongs to a class of drugs known as JAK inhibitors, which block inflammation-causing enzymes, known as Janus kinases, achieved...
AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
